Article
Predicting neoadjuvant chemotherapy benefit using deep learning from stromal histology in breast cancer - npj Breast Cancer
Rating:
0.0
Views:
58
Likes:
1
Library:
1
Neoadjuvant chemotherapy (NAC) is a standard treatment option for locally advanced breast cancer. However, not all patients benefit from NAC; some even obtain worse outcomes after therapy. Hence, predictors of treatment benefit are crucial for guiding clinical decision-making.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value